-
公开(公告)号:WO2023084836A1
公开(公告)日:2023-05-19
申请号:PCT/JP2022/025912
申请日:2022-06-29
申请人: 株式会社島津製作所
发明人: 川上 大輔
IPC分类号: C12Q1/6876 , C12N15/12 , C12Q1/48 , C12Q1/6827 , C12Q1/6858 , C12Q1/686
摘要: 本保存方法は、PCR試薬を保存する方法であって、(1)DNAポリメラーゼを含有する第1組成物、プライマーを含有する第2組成物、および、緩衝液を含有する第3組成物を全て混合して、反応液を調製する工程と、(2)反応液を冷蔵する工程とを順に備え、第1組成物、第2組成物および第3組成物は、それぞれ異なる容器に収容されている。
-
2.
公开(公告)号:WO2023076908A1
公开(公告)日:2023-05-04
申请号:PCT/US2022/078666
申请日:2022-10-25
申请人: GT MOLECULAR, INC.
发明人: KANE, Sarah , NASH, Rose , RAVET, Karl , BARBARI, Stephanie
IPC分类号: C12Q1/686 , C12Q1/6809 , C12Q1/6827 , C12Q1/6876
摘要: Provided herein are methods and kits for discriminating a target sequence from a reference sequence in a polymerase chain reaction (PCR), comprising a labeled probe comprising a fluorophore and a quencher that is complementarity to and specifically binds to the target sequence and may non-specifically bind to the reference sequence and a promiscuity-blocking nucleotide juror oligonucleotide (PBNJ) that specifically binds to the reference sequence and may non-specifically bind to the target sequence, wherein the PBNJ comprises a reference binding region and an extension blocker that prevents elongation by a polymerase.
-
公开(公告)号:WO2023069367A1
公开(公告)日:2023-04-27
申请号:PCT/US2022/046906
申请日:2022-10-17
发明人: LACKEY, Jeremy , BANYAI, William
IPC分类号: C12Q1/6869 , C12M1/34 , C12P19/34 , C12Q1/6834 , C12Q1/6876 , C12Q1/6806
摘要: Provided herein are compositions, devices, systems and methods for polynucleotide sequencing. Further provided are devices comprising surfaces for continuous sequencing. The compositions, devices, systems and methods described herein provide improved storage, density, and retrieval of biomolecule-based information.
-
公开(公告)号:WO2023066257A1
公开(公告)日:2023-04-27
申请号:PCT/CN2022/125976
申请日:2022-10-18
申请人: 珠海横琴爱姆斯坦生物科技有限公司
IPC分类号: C12Q1/686 , C12Q1/6876
摘要: 本发明公开了一种高灵敏度检测细胞群中极少量杂细胞的方法。所述方法为在包含目标细胞和杂细胞的样品中检测所述杂细胞,所述方法检测所述样品中所有细胞的一种或多种特定生物标志物;所述方法包括在提取所述样品的总生物标志物前,将所述样品均分为多个待检组的步骤,所述多个待检组均满足可在体系单次最大灵敏度s内检出一个杂细胞。本发明所述的检测方法可以将灵敏度提高至十万分之一以上。
-
公开(公告)号:WO2023030259A1
公开(公告)日:2023-03-09
申请号:PCT/CN2022/115540
申请日:2022-08-29
申请人: 司法鉴定科学研究院
IPC分类号: C12Q1/6858 , C12Q1/6876 , C12N15/11
摘要: 本发明属于法医学技术领域,提供了一种基于二代测序技术检测微单倍型基因座的引物组合物、试剂盒和方法及其应用,用于扩增人类基因组上163个微单倍型基因座;该引物组合物包括序列如SEQ ID NO.1~326所示的引物中的一对或多对。本发明可用于个人识别、亲缘鉴定和族源推断。
-
公开(公告)号:WO2023025218A1
公开(公告)日:2023-03-02
申请号:PCT/CN2022/114653
申请日:2022-08-25
申请人: 南京金斯瑞生物科技有限公司
IPC分类号: C12Q1/6827 , C12Q1/6858 , C12Q1/686 , C12Q1/6876
摘要: 提供了一种用于检测单碱基突变的引物组和基因芯片方法,其中所述基因芯片方法包括:提供包含待检测的核酸序列的样品;使用引物组通过聚合酶链反应扩增所述样品中的所述待检测的核酸序列,纯化所述聚合酶链反应后的扩增产物,以除去未反应的引物和酶;以及将纯化后的扩增产物与芯片探针杂交,并使用芯片阅读器检测所述待检测的核酸序列的突变信息。该方法在识别碱基突变位点的同时将目标核酸序列进行扩增,不仅实现了检测的增敏,而且基于芯片的高通量点阵,读取速度快等特点,可实现多目标核酸序列的同时快速检测。
-
公开(公告)号:WO2023014898A1
公开(公告)日:2023-02-09
申请号:PCT/US2022/039447
申请日:2022-08-04
申请人: CHROMACODE, INC.
IPC分类号: C12Q1/6844 , C12Q1/6876 , C12Q1/6848 , C12Q1/68 , C12Q1/6853
摘要: Methods, systems, compositions and kits for detection of multiple analytes are disclosed. The methods, systems, compositions and kits may comprise an oligonucleotide that may bind to more than one analyte. The oligonucleotide may allow for the generation of different signal depending on the analyte that the oligonucleotide is hybridized to. The signals generated from may be used to identify the presence of an analyte. The signals generated from may be used may be used to simultaneously identify the presence of multiple analytes in a sample.
-
公开(公告)号:WO2023278802A1
公开(公告)日:2023-01-05
申请号:PCT/US2022/035870
申请日:2022-06-30
IPC分类号: C07K1/00 , C12N15/85 , C12N15/113 , A61K31/712 , A61K48/00 , C12Q1/6876
摘要: Provided herein are formulations configured for the oral delivery of a nucleic acid, such as a non-coding RNA. The formulations provided for herein comprise a plurality of cationic lipids used to encapsulate the nucleic acid within a micelle and a mixture of casein proteins and chitosan polymers used to coat the lipids, which form a coating on the micelle. The coated micelle lends acid-resistance to the formulation such that oral administration is possible with enhanced bioavailability of the nucleic acid to conditions associated with inflammation or fibrosis, such as hypertrophic myocardiopathy, heart failure with preserved ejection fraction, muscle disorders, such as muscular dystrophy, scleroderma and/or viral infection.
-
公开(公告)号:WO2023278799A1
公开(公告)日:2023-01-05
申请号:PCT/US2022/035866
申请日:2022-06-30
IPC分类号: A61K31/712 , A61K48/00 , C12N15/113 , C12Q1/6876 , C07K1/00 , C12N15/85
摘要: An isolated nucleic acid that includes the nucleotide sequence: CGUCCGAUGGUAGUGGGUUAUCAG (SEQ ID NO: 12) is provided. In some embodiment, the nucleic acid includes at least one chemically-modified nucleotide. The nucleic acid and composition containing same find use in treating coniditions associated with inflammation and/or fibrosis, for example, without limitation, heart conditions, such as hypertrophic myocardiopathy, myocardial infarction, and heart failure with preserved ejection fraction; muscle disorders, such as muscular dystrophy; skin disorders, such as scleroderma; and inflammatory conditions, such as autoimmune conditions or inflammatory conditions associated with a viral infection.
-
公开(公告)号:WO2022271857A1
公开(公告)日:2022-12-29
申请号:PCT/US2022/034567
申请日:2022-06-22
发明人: FAHAM, Malek , WU, Johnny , JIANG, Mandy
IPC分类号: C12Q1/6806 , C12Q1/6869 , C12Q1/6886 , C12Q1/6876 , C12Q1/6883
摘要: Provided herein are methods of determining that a subject has or is at risk of having a disease (e.g., cancer) using analysis of gene expression of loci identified in nucleic acid molecules derived from a cell-free biological sample of the subject.
-
-
-
-
-
-
-
-
-